Human MIP-1 beta ELISA ELH-MIP1b-1 from RayBiotech | Biocompare.com

Supplier Images

Image URL

Be the first to write a review!

Citations:

Supplier Page from
RayBiotech for
Human MIP-1 beta ELISA

Description

RayBio® Human MIP-1 beta (CCL4) ELISA Kit for cell culture supernatants, plasma, and serum samples

Product Specs
ItemHuman MIP-1 beta ELISA
CompanyRayBiotech
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberELH-MIP1b-1
Quantity1 x 96-Well Strip Microplate Kit
Detection Range2.5 pg/ml - 1000 pg/ml
Sensitivity2.5 pg/ml
Volume100 µl
Detection TargetMIP-1 beta
NCBI Full Gene NameC-C motif chemokine ligand 4 like 1, C-C motif chemokine ligand 4
NCBI Gene AliasesSCYA4L, SCYA4L1, G-26, ACT2, LAG-1, LAG1, SCYA4, AT744.2, CCL4L, MIP1B1, SCYA4L2, MIP1B, SCYA2, HC21, MIP-1-beta, AT744.1
ApplicationsSandwich-based ELISA Kits
DetectionColorimetric
ReactivityHuman
Sample TypeCell Culture Supernatants, Plasma, Serum

Add to Compare List

RayBiotech

RayBiotech

3607 Parkway Lane, Ste. 200

Norcross, Georgia 30092

United States

Phone: (888) 494-8555
(770) 206-2393

Company Profile

Website: http://www.raybiotech.com

(1) The influence of myeloid-derived suppressor cells on angiogenesis and tumor growth after cancer surgeryInternational journal of cancerJune 1, 2016Wang J, Su X, Yang L, Qiao F, Fang Y, Yu L, Yang Q, Wang Y, Yin Y, Chen R, et al.

(2) Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective studyEuropean journal of clinical investigationJuly 1, 2015Ciaffi L, Cavassini M, Genne D, Delhumeau C, Spycher Elbes R, Hill A, Wandeler G, Fehr J, Stoeckle M, Schmid P, et al.

(3) Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosisBritish journal of haematologyAugust 1, 2013DeAngelo DJ, Mesa RA, Fiskus W, Tefferi A, Paley C, Wadleigh M, Ritchie EK, Snyder DS, Begna K, Ganguly S, et al.

(4) Macrophage inflammatory protein-1β and fibrinogen are synergistic predictive markers of prognosis of intermediate coronary artery lesionsCardiologyJanuary 1, 2012Xu F, Lv S, Chen Y, Song X, Jin Z, Yuan F, Zhou Y, Li H.

Be the First to Write a Review!